Stipple Bio

<cite index="2-5,2-6">Stipple Bio is a biotechnology company that focuses on cellular profiling and target discovery using epitope resolution technology</cite>. <cite index="2-2">Founded in 2021 and based in Cambridge, Massachusetts</cite>, <cite index="21-1">the company was co-founded by Aaron Ring and Aashish Manglik</cite>. <cite index="31-1">The company's Pointillist Platform uncovers novel cancer target binding epitopes against known or novel targets that preferentially bind to tumor but not to healthy tissue</cite>, <cite index="13-6">with the ability to apply proprietary epitopes to multiple modalities including ADCs, TCE, and radiopharmaceuticals</cite>. <cite index="11-9">The platform enables single-cell profiling and target identification for drug discovery and development of cancer immunotherapy</cite>. <cite index="34-7">The company is currently active as a private company</cite>.